Search results for "uterine neoplasm"

showing 10 items of 51 documents

Cytogenetic findings in malignant mixed mesodermal tumors of the uterus.

1997

Abstract Cytogenetic analyses of four malignant mixed mesodermal tumors (MMMT) of the uterus are reported, of which one was of the homologous type and three of the heterologous type. Karyotypic analyses were obtained in two cases from original tumors and in two cases from tumors xenotransplanted into nude mice. The karyotype of the homologous MMMT was normal in three different passages of a nude mice xenograft line established from the primary tumor. The heterologous tumors showed normal karyotype in one case and hyperdiploid and near triploid range with extensive numerical and structural rearrangements in two cases. Deletion of chromosome 1 at p32, and deletion of chromosome 11 at q13 were…

Cancer ResearchPathologymedicine.medical_specialtyUterusHeterologousBiologyMiceGeneticsmedicineHomologous chromosomeAnimalsHumansMolecular BiologyAgedGeneticsChromosome AberrationsMixed Tumor MesodermalCytogeneticsChromosomeKaryotypeMiddle Agedmedicine.diseasePrimary tumormedicine.anatomical_structureIn uteroKaryotypingUterine NeoplasmsFemaleNeoplasm TransplantationCancer genetics and cytogenetics
researchProduct

Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment.

2016

The present study investigated the combination of levonorgestrel-releasing intrauterine device (LNG-IUD) insertion and palliative radiotherapy (RT) as a potential approach for treating frail, elderly endometrial cancer (EC) patients considered unfit for curative oncological treatments. The inclusion criteria were an age of ≥65 years, pathological confirmation of a uterine neoplasm, a Charlson comorbidity index (CCI) value of ≥4 and the presence of vaginal bleeding. Patients underwent intrauterine insertion of an LNG-IUD, and thereafter, received a total dose of 30 Gy at 3 Gy per fraction, over 10 days. The clinical target volume (CTV) was defined as the uterus and disease-involved tissues i…

Cancer Researchmedicine.medical_specialtymedicine.drug_classUterusIntrauterine deviceelderlyuterine cancer03 medical and health sciences0302 clinical medicineUterine cancermedicineVaginal bleedingUterine NeoplasmSettore MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIAprogestin-releasing intrauterine device030219 obstetrics & reproductive medicinebusiness.industryEndometrial cancerCancerArticlesmedicine.diseaseSurgeryElderly; Palliative radiotherapy; Progestin-releasing intrauterine device; Uterine cancer; Oncology; Cancer Researchmedicine.anatomical_structureOncology030220 oncology & carcinogenesispalliative radiotherapymedicine.symptombusinessProgestinOncology letters
researchProduct

Outcomes of in-bag transvaginal extraction in a series of 692 laparoscopic myomectomies: results from a large retrospective analysis

2022

Transvaginal extraction is a feasible method to remove surgical specimen. In this study, we aim to report our experience with in-bag transvaginal specimen retrieval after laparoscopic myomectomy over the past 15 years.Single-center retrospective analysis.Academic hospital.Women who underwent laparoscopic myomectomy from January 2005 to April 2021.Posterior colpotomy and in-bag transvaginal extraction of the surgical specimen.We collected and analyzed data about patients' characteristics, main indication for surgery, and intra- and postoperative (within 30 days) complications.A total of 692 women underwent transvaginal specimen retrieval after laparoscopic myomectomy (mean largest myoma diam…

ComplicationsLeiomyomaLaparoscopic myomectomyObstetrics and GynecologyPosterior colpotomySettore MED/40 - Ginecologia E OstetriciaSurgical specimen retrievalUterine NeoplasmsUterine MyomectomySurgical specimen retrieval.HumansFemaleLaparoscopyComplicationRetrospective StudiesIn-bag transvaginal extraction
researchProduct

Overexpression of the truncated form of high mobility group a proteins (HMGA2) in human myometrial cells induces leiomyoma-like tissue formation

2014

The pathogenesis of uterine leiomyomas, the most common benign tumor in women, is still unknown. This lack of basic knowledge limits the development of novel non-invasive therapies. Our group has previously demonstrated that leiomyoma side population (SP) cells are present in tumor lesions and act like putative tumor-initiating stemcells in human leiomyoma. Moreover, accumulated evidence demonstrates that these benign tumors of mesenchymal origin are characterized by rearrangements of the High Mobility Group A proteins (HMGA). In this work, we tested the hypothesis that leiomyoma development may be due to overexpression of HMGA2 (encoding high mobility group AT-hook2) in myometrial stem cel…

EmbryologyMice SCID//purl.org/becyt/ford/1 [https]MiceMice Inbred NODProtein IsoformsUterine leiomyomaLeiomyomaStem CellsSOMATIC STEM CELLSObstetrics and GynecologyExonsBioquímica y Biología Molecularfemale genital diseases and pregnancy complicationsGene Expression Regulation NeoplasticCell Transformation NeoplasticLeiomyomaUterine NeoplasmsMyometriumNeoplastic Stem CellsFemaleStem cellHIGH MOBILITY GROUP A PROTEINSCIENCIAS NATURALES Y EXACTASPlasmidsAdult stem cellmedicine.medical_specialtyUTERINE LEIOMYOMASMyocytes Smooth MuscleTransplantation HeterologousBiologyTransfectionHUMAN MYOMETRIUMCiencias BiológicasHMGA2Side populationInternal medicineGeneticsmedicineAnimalsHumans//purl.org/becyt/ford/1.6 [https]neoplasmsMolecular BiologyHMGA2 ProteinMesenchymal stem cellHMGASIDE POPULATIONCell Biologymedicine.diseaseIntronsEndocrinologyReproductive MedicineCancer researchbiology.proteinDevelopmental Biology
researchProduct

Impact of oxygenation status and patient age on DNA content in cancers of the uterine cervix.

2003

Abstract Purpose In carcinomas of the uterine cervix, the tumor oxygenation status has been shown to be a prognostic indicator that is independent of treatment modality. In vitro studies suggest gene amplification and polyploidization to be among the major consequences of hypoxia (with or without consecutive reoxygenation) and to be associated with treatment resistance and tumor progression. This study analyzed whether hypoxia alters net DNA content in uterine cervix cancer cells to the extent that it is identifiable by DNA image cytometry. Methods and materials In 64 patients with primary cervical cancer, tumor oxygenation was assessed polarographically and correlated with cell DNA content…

Genome instabilityAdultCancer ResearchPathologymedicine.medical_specialtyGene duplicationMedicineHumansRadiology Nuclear Medicine and imagingDNA Image CytometryAgedImage CytometryCervical cancerAged 80 and overRadiationPloidiesTumor hypoxiabusiness.industryAge FactorsDNA NeoplasmTumor OxygenationHypoxia (medical)Middle Agedmedicine.diseaseCell HypoxiaOxygenOncologyTumor progressionUterine NeoplasmsFemalemedicine.symptombusinessInternational journal of radiation oncology, biology, physics
researchProduct

Molecular and Cellular Insights into the Development of Uterine Fibroids

2021

Uterine leiomyomas represent the most common benign gynecologic tumor. These hormone-dependent smooth-muscle formations occur with an estimated prevalence of ~70% among women of reproductive age and cause symptoms including pain, abnormal uterine bleeding, infertility, and recurrent abortion. Despite the prevalence and public health impact of uterine leiomyomas, available treatments remain limited. Among the potential causes of leiomyomas, early hormonal exposure during periods of development may result in developmental reprogramming via epigenetic changes that persist in adulthood, leading to disease onset or progression. Recent developments in unbiased high-throughput sequencing technolog…

Genome instabilityInfertilitysteroid hormonesUterine fibroidsQH301-705.5ReviewBioinformaticsCatalysistumor-initiating cellEpigenesis GeneticInorganic Chemistrytumor bulk/single-cellsmedicineAnimalsHumansGenetic Predisposition to DiseaseEpigeneticsPhysical and Theoretical ChemistryBiology (General)Molecular BiologyQD1-999genetics/epigeneticsSpectroscopyUterine leiomyomauterine leiomyomaLeiomyomabusiness.industryOrganic ChemistryUterusMyometriumbiomarkersGeneral Medicinemedicine.diseasefemale genital diseases and pregnancy complicationsComputer Science ApplicationsGene Expression Regulation NeoplasticChemistryLeiomyomaMutationUterine Neoplasmstargetable pathwaysFemalebusinessReprogrammingInternational Journal of Molecular Sciences
researchProduct

Menstruation: science and society

2020

© 2020 The Authors Women's health concerns are generally underrepresented in basic and translational research, but reproductive health in particular has been hampered by a lack of understanding of basic uterine and menstrual physiology. Menstrual health is an integral part of overall health because between menarche and menopause, most women menstruate. Yet for tens of millions of women around the world, menstruation regularly and often catastrophically disrupts their physical, mental, and social well-being. Enhancing our understanding of the underlying phenomena involved in menstruation, abnormal uterine bleeding, and other menstruation-related disorders will move us closer to the goal of p…

GerontologyBiomedical ResearchEndometriosisHealth literacyTranslational researchContext (language use)Global HealthEducationMenstruation03 medical and health sciencesEndometrium0302 clinical medicineTerminology as TopicMedicineHumansRegeneration030212 general & internal medicineMenstrual Hygiene ProductsDeveloping CountriesMenstruation DisturbancesReproductive health030219 obstetrics & reproductive medicineLeiomyomaTissue Engineeringbusiness.industryMicrobiotaStem CellsUterusTranslational medicineObstetrics and GynecologyNational Institute of Child Health and Human Development (U.S.)Mesenchymal Stem CellsCongresses as TopicMicrofluidic Analytical Techniquesmedicine.diseaseBiological EvolutionUnited StatesHealth LiteracyMenstruationMenopauseAttitudeUterine NeoplasmsMenarcheWomen's HealthFemaleUterine HemorrhagebusinessAdenomyosis
researchProduct

Identification and characterization of the human leiomyoma side population as putative tumor-initiating cells.

2012

Objective To isolate and characterize human leiomyoma stem cells by the side population (SP) method. Design Prospective experimental human and animal study. Setting University research laboratory-affiliated infertility clinic. Patient(s) Women undergoing laparoscopic myomectomy. Animal(s) Female non-obese diabetic severe combined immune deficiency (NOD-SCID) mutation mice. Intervention(s) Obtainment of human leiomyoma SP cells as candidate tumor-initiating cells and establishment of two leiomyoma SP lines. Main Outcome Measure(s) Flow cytometry, semiquantitative polymerase chain reaction, clonogenicity assays, cDNA microarrays hybridization, cell culture, karyotype, molecular analysis, immu…

Homeobox protein NANOGPathologymedicine.medical_specialtyCD34BiologyMiceSide populationCell Line TumormedicineAnimalsHumansCD90Prospective StudiesSide-Population CellsLeiomyomaMesenchymal stem cellObstetrics and GynecologyHematopoietic stem cellmedicine.diseasemedicine.anatomical_structureLeiomyomaReproductive MedicineUterine NeoplasmsCancer researchNeoplastic Stem CellsFemaleStem cellFertility and sterility
researchProduct

Endometrial receptivity and implantation are not affected by the presence of uterine intramural leiomyomas: a clinical and functional genomics analys…

2008

Uterine leiomyomas are the most frequent benign tumors during reproductive age. Whether intramural leiomyomas cause infertility and should be removed is controversial because no study has addressed the underlying mechanism of infertility.The objective of the study was to test the effect of intramural leiomyomas on endometrial function by comparing gene during the window of implantation and implantation in an oocyte donation program, in which the quality of the embryos replaced is similar and the endocrine environment of the endometrium is standardized by exogenous steroids.Human endometria of women with single intramural leiomyomas (group A,5 cm and group B,or =5 cm) and controls (group C) …

InfertilityAdultmedicine.medical_specialtyPregnancy RateEndocrinology Diabetes and Metabolismmedicine.medical_treatmentClinical BiochemistryUterusContext (language use)BiologyEndometriumBiochemistryModels BiologicalEndometriumEndocrinologyPregnancyInternal medicinemedicineCluster AnalysisHumansEmbryo ImplantationOligonucleotide Array Sequence AnalysisRetrospective StudiesGynecologyIn vitro fertilisationUterine leiomyomaLeiomyomaGene Expression ProfilingBiochemistry (medical)GenomicsMiddle Agedmedicine.diseaseGene Expression Regulation NeoplasticPregnancy ratemedicine.anatomical_structureEndocrinologyIn uteroUterine NeoplasmsFemalePregnancy Complications NeoplasticThe Journal of clinical endocrinology and metabolism
researchProduct

The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing.

2019

BACKGROUND: Although uterine leiomyomas and leiomyosarcomas are considered biologically unrelated tumors, they share morphologic and histologic characteristics that complicate their differential diagnosis. The long-term therapeutic option for leiomyoma is laparoscopic myomectomy with morcellation, particularly for patients who wish to preserve their fertility. However, because of the potential dissemination of undiagnosed or hidden leiomyosarcoma from morcellation, there is a need to develop a preoperative assessment of malignancy risk. OBJECTIVE: Through an integrated comparative genomic and transcriptomic analysis, we aim to identify differential genetic targets in leiomyomas vs leiomyosa…

LeiomyosarcomaAdultLeiomyosarcomaDNA Copy Number Variationsmedicine.disease_causeMalignancyPolymorphism Single NucleotideDNA sequencinggenomic/transcriptomic profileuterine leiomyosarcomaDiagnosis Differential03 medical and health sciences0302 clinical medicineGene DuplicationmedicineHumans030212 general & internal medicineCopy-number variationGeneAgedMutation030219 obstetrics & reproductive medicineuterine leiomyomaLeiomyomabusiness.industrySequence Analysis RNAGene Expression ProfilingObstetrics and GynecologyHigh-Throughput Nucleotide SequencingGenomicsSequence Analysis DNAMiddle Agedmedicine.diseaseBRCA2body regionsLeiomyomaUterine NeoplasmsCancer researchFGFR4FemaleDifferential diagnosisGene FusionbusinessROS1DNA/RNA sequencingGene DeletionAmerican journal of obstetrics and gynecology
researchProduct